Paris-based baCta secured €7 million Seed funding to develop microorganisms as programmable molecula...
The AMW Read
The article updates the player map for the AI-biology vertical with a seed-stage funding announcement for baCta, though it does not meet the $500M threshold for cross.§D.
Paris-based baCta secured €7 million Seed funding to develop microorganisms as programmable molecular factories, targeting the $6.86 billion astaxanthin market projected by 2034. The company's AI-driven platform baCtaForge explores genomic 'dark matter' using reinforcement learning, dramatically accelerating strain engineering beyond traditional trial-and-error methods that have bottleneck industrial bioproduction. With backing from LocalGlobe, Daphni, and founders of MistralAI, this signals strong investor confidence in AI-biology convergence to replace petrochemical supply chains with sustainable, resilient alternatives. baCta's total funding now exceeds €10 million, with first product targeting synthetic astaxanthin alternatives across nutraceuticals, cosmetics, and animal feed markets.
#SyntheticBiology #AIBiotech #SustainableManufacturing #IndustrialBiotech #Bioproduction
